Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 2021

View Archived Issues

IL-36-gamma is a marker of enthesitis-related arthritis

Preclinical data presented on INBRX-121 as monotherapy or in combination with IO therapy regimens

Novel pan-ERR agonists can provide cardioprotection against heart failure

Plexin D1-positive extracellular vesicles as potential biomarker of polymyositis and dermatomyositis

Increased BMP-10 activity tied to disease severity in pulmonary hypertension

Assembly Biosciences patents new compounds for HBV

Chinese researchers divulge GTPase KRAS mutant inhibitors

IMMvention Therapeutix synthesizes NLRP3 inflammasome inhibitors

Shenzhen Jingtai Technology discloses new Ret inhibitors

Accutar Biotechnology describes new compounds for cancer

Promising in vivo PK and toxicity data presented for GS-3583

U.K. study illuminates value of whole genome sequencing in rare disease care

BetterLife reports first behavioral animal pharmacology data on TD-0148A

Pyramid licenses rights to MPS1 inhibitor VRN-08 from Voronoi

Researchers unveil CCN1 as a therapeutic target for rheumatoid arthritis

CRV-431 significantly decreases growth of liver tumors in mouse model of liver cancer

New mouse model allows assessment of HTT mRNA targeting compounds for Huntington's disease

Novoron secures funding to support development of NOVO-118 for spinal cord injury and MS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...